Wälchli S - Search Results

1

Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16.

Casey NP, Kleinmanns K, Forcados C, Gelebart PF, Joaquina S, Lode M, Benard E, Kaveh F, Caulier B, Helgestad Gjerde C, García de Jalón E, Warren DJ, Lindemann K, Rokkones E, Davidson B, Myhre MR, Kvalheim G, Bjørge L, McCormack E, Inderberg EM, Wälchli S. Casey NP, et al. Among authors: walchli s. J Immunother Cancer. 2024 Apr 11;12(4):e008179. doi: 10.1136/jitc-2023-008179. J Immunother Cancer. 2024. PMID: 38604812 Free PMC article.

2

Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells.

Stronen E, Abrahamsen IW, Gaudernack G, Wälchli S, Munthe E, Buus S, Johansen FE, Lund-Johansen F, Olweus J. Stronen E, et al. Among authors: walchli s. Scand J Immunol. 2009 Apr;69(4):319-28. doi: 10.1111/j.1365-3083.2008.02223.x. Scand J Immunol. 2009. PMID: 19284496 Free article.

3

Protein tyrosine phosphatases as drug targets: PTP1B and beyond.

Hooft van Huijsduijnen R, Wälchli S, Ibberson M, Harrenga A. Hooft van Huijsduijnen R, et al. Among authors: walchli s. Expert Opin Ther Targets. 2002 Dec;6(6):637-47. doi: 10.1517/14728222.6.6.637. Expert Opin Ther Targets. 2002. PMID: 12472377 Review.

4

Sap-1/PTPRH activity is regulated by reversible dimerization.

Wälchli S, Espanel X, Hooft van Huijsduijnen R. Wälchli S, et al. Biochem Biophys Res Commun. 2005 Jun 3;331(2):497-502. doi: 10.1016/j.bbrc.2005.03.196. Biochem Biophys Res Commun. 2005. PMID: 15850787

5

Pulling strings below the surface: hormone receptor signaling through inhibition of protein tyrosine phosphatases.

Espanel X, Wälchli S, Gobert RP, El Alama M, Curchod ML, Gullu-Isler N, Hooft van Huijsduijnen R. Espanel X, et al. Among authors: walchli s. Endocrine. 2001 Jun;15(1):19-28. doi: 10.1385/endo:15:1:019. Endocrine. 2001. PMID: 11572321 Review.

6

MetaBlasts: tracing protein tyrosine phosphatase gene family roots from Man to Drosophila melanogaster and Caenorhabditis elegans genomes.

Wälchli S, Colinge J, Hooft van Huijsduijnen R. Wälchli S, et al. Gene. 2000 Aug 8;253(2):137-43. doi: 10.1016/s0378-1119(00)00275-4. Gene. 2000. PMID: 10940550

7

Transiently redirected T cells for adoptive transfer.

Almåsbak H, Rian E, Hoel HJ, Pulè M, Wälchli S, Kvalheim G, Gaudernack G, Rasmussen AM. Almåsbak H, et al. Among authors: walchli s. Cytotherapy. 2011 May;13(5):629-40. doi: 10.3109/14653249.2010.542461. Epub 2010 Dec 21. Cytotherapy. 2011. PMID: 21174490

8

T-helper cell receptors from long-term survivors after telomerase cancer vaccination for use in adoptive cell therapy.

Kyte JA, Gaudernack G, Faane A, Lislerud K, Inderberg EM, Brunsvig P, Aamdal S, Kvalheim G, Wälchli S, Pule M. Kyte JA, et al. Among authors: walchli s. Oncoimmunology. 2016 Oct 24;5(12):e1249090. doi: 10.1080/2162402X.2016.1249090. eCollection 2016. Oncoimmunology. 2016. PMID: 28123886 Free PMC article.

9

T cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces in vivo tumor growth.

Inderberg EM, Wälchli S, Myhre MR, Trachsel S, Almåsbak H, Kvalheim G, Gaudernack G. Inderberg EM, et al. Among authors: walchli s. Oncoimmunology. 2017 Mar 17;6(4):e1302631. doi: 10.1080/2162402X.2017.1302631. eCollection 2017. Oncoimmunology. 2017. PMID: 28507809 Free PMC article.

10

A TCR-based Chimeric Antigen Receptor.

Walseng E, Köksal H, Sektioglu IM, Fåne A, Skorstad G, Kvalheim G, Gaudernack G, Inderberg EM, Wälchli S. Walseng E, et al. Among authors: walchli s. Sci Rep. 2017 Sep 6;7(1):10713. doi: 10.1038/s41598-017-11126-y. Sci Rep. 2017. PMID: 28878363 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

92 results

Search Page